SAR288 has emerged as a novel therapeutic target for COVID-19. This pharmaceutical agent exhibits potent antiviral activity against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://violabfiz502657.activoblog.com/46124772/a-novel-therapeutic-target-for-covid-19